Azilsartan Hair Loss: Risk, Timeline & Fixes

Last updated How we write and review our guides

Diarrhea is the headline adverse reaction on the US azilsartan label: 2% of adults, against 0.5% on placebo in the 80 mg monotherapy trials. Hair is not mentioned anywhere in the label text I read, or in the UK and EU product information for Edarbi.[1][2]

That silence is useful but limited, and it is the starting point for thinking about azilsartan hair loss. Without a label entry to point to, the question becomes practical: does the timing of your shedding fit telogen effluvium, is the pattern diffuse, and what else changed in those months? The sections below take those questions in turn.

Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change azilsartan without clinician guidance. If you are not sure whether you are seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, facial swelling, or rapid worsening, start here: When to See a Doctor.

Azilsartan hair loss: ARB shedding, telogen effluvium timing, diffuse pattern clues, overlap triggers, labs, and practical next steps.
Suspected azilsartan-related shedding is usually best interpreted through delayed telogen effluvium timing and a diffuse pattern, not a sudden one-week cause.

Key points


Quick navigation


What the product information says (and doesn’t)

US labeling (Edarbi)

  • Most common reaction: diarrhea (2% in adults; up to 2% with Edarbi 80 mg versus 0.5% with placebo in monotherapy trials).[1]
  • Other reactions with a plausible relationship to treatment (at least 0.3% and above placebo): nausea, asthenia, fatigue, muscle spasm, dizziness, postural dizziness and cough.[1]
  • Withdrawals due to adverse events: 2.4% (19 of 801) with placebo, 2.2% (24 of 1,072) with 40 mg and 2.7% (29 of 1,074) with 80 mg.[1]
  • Post-marketing skin reports: rash, pruritus and angioedema. Alopecia is not listed.[1]

UK/EU product information

  • The Edarbi SmPC (Takeda, revised January 2025) lists rash, pruritus and angioedema as “uncommon” and diarrhea as “common.” Alopecia and hair loss do not appear.[2]
  • It also states that rebound hypertension was not observed after abrupt cessation following 6 months of treatment.[2]

Combination tablets (azilsartan with chlorthalidone)

The Edarbyclor page I read lists pruritus and angioedema as post-marketing reactions and has no alopecia entry, but it was one section of the label and did not include the clinical-trial adverse reaction tables.[3] If you take a combination tablet, the second ingredient has its own label; see our chlorthalidone page.

How it compares with other ARBs

The US candesartan and telmisartan labels I read do not name alopecia either,[4][5] while the US olmesartan and valsartan labels list it among post-marketing reports.[6][7] See our candesartan, telmisartan, olmesartan and valsartan pages for details. DermNet’s list of drugs that cause TE names antihypertensives only as “beta-blockers, ACE inhibitors,” and I found no published case reports for azilsartan.[10]

What this means in practice: an absent label entry lowers the likelihood that azilsartan is the culprit, but it cannot rule it out, because rare reactions may never reach a label. The decision should rest on whether the timeline fits TE, whether the pattern is diffuse, and whether there were other triggers in the same window.

Timeline: onset, shedding phase, recovery

  • Onset: the key clue is delay. DermNet says hair fall is noticed 2 to 4 months after the trigger; BAD says it can occur around 3 months after.[8][9]
  • Shedding phase: BAD gives 3 to 6 months, and calls TE chronic if it lasts more than 6 months.[9]
  • Recovery: DermNet says hair fall tapers back to normal over 6 to 9 months in most cases, and BAD says it may take many months for hair to return to normal volume and thickness.[8][9]
  • If a drug is the cause and is stopped under medical advice: DermNet says shedding settles within up to 6 months, with regrowth visible within 3 to 6 months and cosmetic recovery sometimes taking 12 to 18 months.[10]

This delay is why the link is easy to miss: someone starts azilsartan, feels stable for weeks, and only later notices more hair in the shower, on the pillow or on the brush. The same window also fits illness, surgery, weight change or stress.

Pattern clues: TE vs AGA vs AA vs breakage

Most consistent with TE

Medication-linked or trigger-linked TE usually looks like diffuse shedding with a generally normal-looking scalp: more hair fall all over, not one sharply defined bald patch.

TE + androgenetic alopecia overlap

If shedding improves but the part line keeps widening or the crown continues to thin, think about overlap with telogen effluvium vs androgenetic alopecia.

Alopecia areata is a different pattern

If you have patchy, smooth, well-defined bald areas, that is less typical for medication-triggered TE and should raise the question of alopecia areata.

Breakage is not the same as shedding

If you mostly see short snapped hairs, rough texture or frayed ends, that points more toward hair breakage than true root-level shedding.

If the scalp is inflamed, think broader than TE

TE is typically non-scarring and without obvious inflammation. If the scalp is very itchy, red, painful or crusted, a simple TE explanation is incomplete; see Itchy Scalp and Hair Loss.

When labs matter

Not everyone with a plausible timeline needs a broad lab panel. DermNet lists at least a blood count, iron studies and thyroid function tests when the cause is unclear, and BAD mentions blood tests to exclude conditions such as thyroid problems and iron deficiency.[10][9] They matter most when shedding is heavy, persistent or recurrent, or the history suggests iron deficiency, thyroid disease, major weight change, illness or dietary restriction in the same window.

For the site workup roadmap, use: Blood Tests & Workup. For the most common overlaps, see low ferritin and shedding and thyroid hair loss vs TE.

What to do (practical plan)

  1. Build the timeline: write down the azilsartan start date, any dose changes, and the month shedding became noticeable.
  2. Confirm the pattern: diffuse shedding vs breakage vs overlapping pattern hair loss vs patchy loss.
  3. Review stacked triggers: illness, fever, surgery, postpartum timing, dieting, weight loss, thyroid issues, low iron or major stress. BAD notes that for 1 in 3 people with TE no cause is found, and DermNet suggests looking back over the three months before the hair loss began.[9][10]
  4. Check the exact formulation: azilsartan alone versus a combination with chlorthalidone (Edarbyclor), because each ingredient has its own label.[3]
  5. Talk to the prescriber: if the timing fits, discuss whether to wait and watch or consider an alternative, weighing the cardiovascular benefit. Do not self-stop.
  6. Avoid supplement roulette: BAD advises supplements only if your diet is restricted, and notes that medication does not speed up TE regrowth.[9]
  7. Track monthly: photos every 4 weeks in the same lighting and angle, to judge the trend rather than day-to-day anxiety.

Stress is a common co-trigger; see Hair Loss After Stress.

When to see a doctor

  • Scalp pain, burning, pustules, open sores, or heavy scale/crusting
  • Patchy smooth bald spots rather than diffuse shedding
  • Obvious eyebrow or eyelash involvement
  • Facial, lip or tongue swelling, or hives: seek urgent care, since angioedema is a reported reaction to azilsartan
  • Diarrhea that is persistent or comes with weight loss
  • Shedding that persists beyond about 6 months or returns in repeated waves
  • Unclear diagnosis or rapid worsening

Start here: When to See a Doctor.


FAQ

Does azilsartan (Edarbi) cause hair loss?

The labels I read do not list it, and I found no published case reports, so there is no documented link.[1][2] That does not exclude an individual reaction, so the timeline and other triggers still need to be reviewed.

Could diarrhea on azilsartan affect my hair?

Diarrhea is the most common reaction on the label (“common” in the UK/EU document).[1][2] DermNet lists weight loss and nutritional deficiency among TE triggers,[8] so persistent diarrhea with weight loss is worth raising with your doctor, because it can matter for general health as well as hair.

Does that mean azilsartan cannot be related to my shedding?

No. It means the direct label support is weaker than for medicines that do list alopecia. Whether the drug fits depends on timing, pattern and whether other triggers were present in the same window.

Do Edarbyclor or other combination tablets carry the same risk?

The Edarbyclor page I read has no alopecia entry, but it did not include the trial tables, and the chlorthalidone component has its own label; see our chlorthalidone page.[3]

Why does shedding start months later?

Because TE is delayed: the trigger shifts more hairs into the resting phase first, and the increased shedding becomes noticeable once those hairs are pushed out, typically 2 to 4 months later.[8]

Is hair loss on azilsartan permanent?

When the pattern behaves like TE, it is non-scarring and generally reversible once the trigger resolves, but recovery is slow: DermNet describes tapering over 6 to 9 months in most cases.[8]

Should I stop azilsartan if I suspect shedding?

No, not on your own. The UK/EU information says rebound hypertension was not observed after abrupt cessation, but that does not mean blood pressure stays controlled without treatment.[2] Review the timeline and treatment context with the prescriber first.


References (trusted sources)

  1. DrugCentral: Edarbi (azilsartan medoxomil) full label text (leaflet revised March 2020) — trial adverse reactions, withdrawals and post-marketing list
  2. UK electronic medicines compendium: Edarbi 20 mg/40 mg/80 mg tablets SmPC (Takeda, revised January 2025)
  3. Medlibrary: Edarbyclor (azilsartan medoxomil/chlorthalidone) prescribing information, post-marketing experience
  4. Medlibrary: Atacand (candesartan cilexetil) prescribing information, post-marketing experience
  5. Medlibrary: Micardis (telmisartan) prescribing information, post-marketing experience
  6. Medlibrary: Benicar (olmesartan medoxomil) prescribing information, post-marketing experience
  7. Medlibrary: Diovan (valsartan) prescribing information, post-marketing experience
  8. DermNet NZ: Telogen effluvium (hair fall noticed 2–4 months after trigger)
  9. British Association of Dermatologists (Skin Health Info): Telogen effluvium (around 3 months after a trigger)
  10. DermNet NZ: Alopecia from drugs

TOUATI

I have lived with hair loss since 2019. After consulting several doctors and researching every day, I founded Hair Health Blog to share clear, evidence-based answers with people facing the same problem. Not a doctor; always consult a dermatologist.facebook instagram

Previous Post Next Post

Contact Form